Pamukcu Rifat

Pamukcu Rifat is listed in filings as Director at Aprea Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jun 9, 2025, including 4 public disclosures. Recent filings connect the profile to Aprea Therapeutics, Inc. (APRE). The current snapshot covers public activity from Jun 21, 2024 to Jun 9, 2025. Reported amounts are shown as $7.6K to $17.0K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.